Antonio Giordano/X
Apr 14, 2025, 16:49
Antonio Giordano’s Novel Work Offers New Hope in the Fight Against Cancer – Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X:
“Dr. Antonio Giordano’s novel work on a next-generation CDK4/6 inhibitor is offering new hope to patients like Ellie Destito, who had exhausted standard treatments.
What began as an unnamed drug in a phase 1 trial is now being evaluated in a phase 3 trial bringing new optimism to patients and researchers alike in the fight against.”
Antonio Giordano, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared this post, adding:
“I love this story, you are a rockstar!
Thank you Dana-Farber’s CCTI to make phase 1 trials possible and give new hopes to patients with metastatic cancer!”
More posts featuring Breast Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 19:09
May 29, 2025, 17:58
May 29, 2025, 17:45
May 29, 2025, 17:39